- Advertisement -
Trends News Stories covers trending news across technology, health, entertainment, sports, and business.
Trends News Stories Editorial
3661 POSTS
0 COMMENTS
Editorial desk at Trends News Stories (trendsnewsstories.com), an independent news site based in New Delhi, India. We publish original trending-news explainers across entertainment, sports, tech, business and health. Facts are checked against official sources and trusted outlets; we credit sources, note what is unconfirmed, and correct errors when we find them.
AI Series The Arc Made for Just $38,000 in Credits
The AI series The Arc, an 83-minute sci-fi production, was finished in just three and a half weeks for $38,000 in compute credits. A landmark run.
Starlink Disruption Probe Demanded by US Lawmakers
Senior US lawmakers demanded a congressional probe into the Starlink disruption affecting Ukraine, after Zelenskyy said restrictions came from Washington.
Jordan Love Rushing Touchdown Sparks Packers Past Cowboys
Jordan Love scored his first rushing touchdown since 2024 as the Packers dominated the Cowboys on Sunday night, going up 17-0 in the rout late.
Tre Tucker Stars as Bills Edge Raiders 33-30
Tre Tucker caught 5 passes for 97 yards and 2 TDs as the Raiders nearly upset the Bills, but Buffalo held on 33-30 after Shakir's onside kick.
Oso Ighodaro Extension: Suns Agree to $29M Deal
The Suns agreed to a three-year, $29 million rookie extension with Oso Ighodaro, securing their young big man before Monday's rookie deadline.
Cason Wallace Extension: Thunder Lock Up Guard for $139M
The Thunder agreed to a five-year, $139 million rookie extension with Cason Wallace, locking up their All-Defensive guard before the deadline.
Rays ALCS Lead: Tampa Bay One Win From World Series
The Rays took a 3-2 ALCS lead over Cleveland with a 3-1 win, as Drew Rasmussen starred to put Tampa Bay one victory from the World Series on Sunday.
CytoDyn Webcast Today: Leronlimab Update Investors Await
CytoDyn hosts an investor webcast today at 1 p.m. PT with updates on leronlimab, its Natera collaboration, early CLOVER data and 2026 milestones.
Azenosertib Ovarian Cancer Data Shows 15.8-Month Survival
Zentalis reported 15.8-month median overall survival for azenosertib in ovarian cancer patients, with full data due at ESMO Congress on Oct 23.
Infant Formula Botulism Testing Petition Filed With FDA
A new FDA petition seeks to add botulism to the infant formula testing list, with public comments sought from scientists, parents and manufacturers.
- Advertisement -
